Potential new therapy for Glaucoma Sufferers
Tuesday 02 January 2018Researchers at Stanford University are experimenting with a new treatment for Glaucoma which could completely change our thinking about therapy for the condition.
Currently, treatments focus on the symptoms of the disease. This involves relieving the eye pressure that sufferers experience. This can involve eye drops, oral drugs and laser therapy or surgery. The new pathway concentrates on stopping the degeneration in the first place by the use of powerful molecules known as lipoxins.
Researchers have had success testing lipoxins on rodents, and hope to trial the treatment on humans in the near future. The exciting discovery also offers the potential to prevent other neurodegenerative diseases such as Alzheimer’s and Parkinsons.
Sources:
Subscribe to our email newsletter and claim your FREE copy of our popular guide '9 Top Tips to Save Your Sight'
Comments
Post a comment…
A Serious Blog
News and views from around the world on lighting, eyecare and eye conditions.
Twitter: @seriousreaders
Facebook:facebook.com/seriousreaders
Recent posts
- World Book and Copyright Day
- Spring forward: Your guide to the 2024 British Summer Time shift
- A spark of genius - the history of the light bulb
- A worded world: Celebrating the Oxford English Dictionary's legacy
- High street cataract and glaucoma tests to reduce NHS waiting lists?
Browse by label
- AMD
- AMD Sight News
- Blue Light
- Cataracts
- Diabetic Retinopathy
- Glaucoma
- Glaucoma Sight News
- Light News
- Light News Glaucoma Sight News
- Light News Sight News
- Literary Festivals
- Literary Festivals Literary News
- Literary News
- OCT Scans: A New Tool In Multiple Sclerosis Diagnosis
- Serious News
- Sight News
- Sight News AMD
- Sight News Blue Light
- Sight News Cataracts
- Sight News Glaucoma
Any more information on provision of Lumigan and Cosopt in non-allergic formulae would be interesting.